Moreover, cancer and its therapies adversely affect various metabolic processes in the body influencing factors such as weight changes, fat metabolism, energy regulation, dyslipidemia, growth hormone regulation, and cardiovascular health. Here, GH1 is linked to metabolic syndrome.